Low serum SHBG concentrations are considered to be a biomarker of metabolic abnormalities and they are linked to insulin resistance (IR), hyperandrogenemia, hyperglycemia, and dyslipidemia in PCOS patients. The gene discussed is SHBG; the disease is polycystic ovary syndrome.